Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Current Leases (2022 - 2025)

PAVmed has reported Current Leases over the past 4 years, most recently at $573000.0 for Q4 2025.

  • Quarterly results put Current Leases at $573000.0 for Q4 2025, up 11.7% from a year ago — trailing twelve months through Dec 2025 was $573000.0 (up 11.7% YoY), and the annual figure for FY2025 was $573000.0, up 11.7%.
  • Current Leases for Q4 2025 was $573000.0 at PAVmed, up from $557000.0 in the prior quarter.
  • Over the last five years, Current Leases for PAVM hit a ceiling of $1.6 million in Q3 2023 and a floor of $513000.0 in Q4 2024.
  • Median Current Leases over the past 4 years was $985000.0 (2022), compared with a mean of $1.0 million.
  • Biggest five-year swings in Current Leases: skyrocketed 53.26% in 2023 and later tumbled 67.22% in 2024.
  • PAVmed's Current Leases stood at $1.1 million in 2022, then soared by 37.16% to $1.6 million in 2023, then crashed by 67.22% to $513000.0 in 2024, then grew by 11.7% to $573000.0 in 2025.
  • The last three reported values for Current Leases were $573000.0 (Q4 2025), $557000.0 (Q3 2025), and $542000.0 (Q2 2025) per Business Quant data.